These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9771965)
1. Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C. Townsend KJ; Trusty JL; Traupman MA; Eastman A; Craig RW Oncogene; 1998 Sep; 17(10):1223-34. PubMed ID: 9771965 [TBL] [Abstract][Full Text] [Related]
2. MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Domina AM; Vrana JA; Gregory MA; Hann SR; Craig RW Oncogene; 2004 Jul; 23(31):5301-15. PubMed ID: 15241487 [TBL] [Abstract][Full Text] [Related]
3. Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition. Domina AM; Smith JH; Craig RW J Biol Chem; 2000 Jul; 275(28):21688-94. PubMed ID: 10777489 [TBL] [Abstract][Full Text] [Related]
4. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents. Vrana JA; Cleaveland ES; Eastman A; Craig RW Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109 [TBL] [Abstract][Full Text] [Related]
5. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation. Townsend KJ; Zhou P; Qian L; Bieszczad CK; Lowrey CH; Yen A; Craig RW J Biol Chem; 1999 Jan; 274(3):1801-13. PubMed ID: 9880563 [TBL] [Abstract][Full Text] [Related]
6. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Stone AA; Chambers TC Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471 [TBL] [Abstract][Full Text] [Related]
7. Ultraviolet-induced junD activation and apoptosis in myeloblastic leukemia ML-1 cells. Li T; Dai W; Lu L J Biol Chem; 2002 Sep; 277(36):32668-76. PubMed ID: 12082101 [TBL] [Abstract][Full Text] [Related]
8. EGF-mediated phosphorylation of extracellular signal-regulated kinases in osteoblastic cells. Zhang W; Dziak RM; Aletta JM J Cell Physiol; 1995 Mar; 162(3):348-58. PubMed ID: 7860643 [TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells. Blagosklonny MV; Chuman Y; Bergan RC; Fojo T Leukemia; 1999 Jul; 13(7):1028-36. PubMed ID: 10400418 [TBL] [Abstract][Full Text] [Related]
10. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. Wang TH; Wang HS; Ichijo H; Giannakakou P; Foster JS; Fojo T; Wimalasena J J Biol Chem; 1998 Feb; 273(9):4928-36. PubMed ID: 9478937 [TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Persons DL; Yazlovitskaya EM; Cui W; Pelling JC Clin Cancer Res; 1999 May; 5(5):1007-14. PubMed ID: 10353733 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42. Levi NL; Hanoch T; Benard O; Rozenblat M; Harris D; Reiss N; Naor Z; Seger R Mol Endocrinol; 1998 Jun; 12(6):815-24. PubMed ID: 9626657 [TBL] [Abstract][Full Text] [Related]
13. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis. Stadheim TA; Kucera GL Biochem Biophys Res Commun; 1998 Apr; 245(1):266-71. PubMed ID: 9535820 [TBL] [Abstract][Full Text] [Related]
14. Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. Geng Y; Valbracht J; Lotz M J Clin Invest; 1996 Nov; 98(10):2425-30. PubMed ID: 8941662 [TBL] [Abstract][Full Text] [Related]
15. Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways. Jun CD; Pae HO; Kwak HJ; Yoo JC; Choi BM; Oh CD; Chun JS; Paik SG; Park YH; Chung HT Cell Immunol; 1999 May; 194(1):36-46. PubMed ID: 10357879 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Shtil AA; Mandlekar S; Yu R; Walter RJ; Hagen K; Tan TH; Roninson IB; Kong AN Oncogene; 1999 Jan; 18(2):377-84. PubMed ID: 9927194 [TBL] [Abstract][Full Text] [Related]
17. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1. Lee YC; Chen YJ; Huang CH; Chang LS Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735 [TBL] [Abstract][Full Text] [Related]
18. Induction of BCL2 family member MCL1 as an early response to DNA damage. Zhan Q; Bieszczad CK; Bae I; Fornace AJ; Craig RW Oncogene; 1997 Mar; 14(9):1031-9. PubMed ID: 9070651 [TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin potentiates the protein-kinase-C-mediated activation of mitogen-activated protein kinase/ERK kinases and extracellular signal-regulated kinases in human platelets. Ezumi Y; Uchiyama T; Takayama H Eur J Biochem; 1998 Dec; 258(3):976-85. PubMed ID: 9990315 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of mitogen-activated protein kinase activation by gonadotropin-releasing hormone in the pituitary of alphaT3-1 cell line: differential roles of calcium and protein kinase C. Reiss N; Llevi LN; Shacham S; Harris D; Seger R; Naor Z Endocrinology; 1997 Apr; 138(4):1673-82. PubMed ID: 9075730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]